Staar Surgical (STAA) Cash from Financing Activities (2010 - 2026)

Staar Surgical (STAA) has 17 years of Cash from Financing Activities data on file, last reported at -$1.7 million in Q2 2026.

• For the quarter ending Q2 2026, Cash from Financing Activities fell 78.59% year-over-year to -$1.7 million; the trailing twelve-month figure through Apr 2026 stood at -$5.3 million (down 836.11% YoY), and the FY2026 full-year result was -$4.6 million, down 179.58% from the prior year.
• Cash from Financing Activities for Q2 2026 stood at -$1.7 million, down from -$50000.0 in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $7.1 million in Q3 2023 and bottomed at -$4.5 million in Q2 2025.
• The 5-year median for Cash from Financing Activities is $367000.0 (2023), against an average of $893411.8.
• The widest annual swing landed in 2024, when Cash from Financing Activities soared 398.02%; it then slumped 2885.28% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at $202000.0 in 2022, then soared by 81.68% to $367000.0 in 2023, then tumbled by 129.97% to -$110000.0 in 2024, then soared by 993.64% to $983000.0 in 2025, then plunged by 272.23% to -$1.7 million in 2026.
• The last three Cash from Financing Activities figures came in at -$1.7 million (Q2 2026), -$50000.0 (Q1 2026), and $983000.0 (Q3 2025), per Business Quant data.

Peer Comparison